Skip to content
Main Navigation
About us
Company profile
Our values
Our strategy
Board of Directors
Senior management
Our history
Research and development
Technology platform
Therapeutic areas
Pipeline
Scientific papers and presentations
Partnering
Our approach
Our partnerships
Investors
Financial reports and presentations
Share information
Analyst coverage
Major shareholders
Financial calendar
Corporate governance
Corporate governance statements
Dividend policy
Annual general meeting
Articles of association
Safe harbour statement
Whistleblower policy
Risk management
Investor relations policy
ESG
Email alerts
Media
News and announcements
Image library
Glossary
Email alerts
Careers
Life at Nykode
Meet us
Open positions
Search
Media
News and Announcements
Newest first
Oldest first
Announcements
News
Search
Reset
13/11/2019
STATUS OF THE CANCER VACCINE FIELD AND DEVELOPMENT OF NOVEL IMMUNOTHERAPIES, CAPITAL MARKETS DAY – OSLO, 12 NOVEMBER 2019
13/11/2019
VACCIBODY TO HOST CAPITAL MARKETS DAY IN OSLO ON 12TH NOVEMBER 2019
05/11/2019
VACCIBODY ANNOUNCES INITIAL POSITIVE CLINICAL RESPONSES IN PATIENTS WITH LOCALLY ADVANCED OR METASTATIC CANCER TREATED WITH VB10.NEO NEOANTIGEN CANCER VACCINE
02/11/2019
VACCIBODY TO HOST CAPITAL MARKETS DAY IN OSLO ON 12TH NOVEMBER 2019
11/10/2019
VACCIBODY APPOINTS NEW CHIEF MEDICAL OFFICER
Pages:
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
Load more
Sorry, nothing found in this query
Privacy statement
Cookie policy
Disclaimer